Valiant Laboratories Ltd

543998

Overview

    • Equity Style Box

      Small Value

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      115.45 – 118.95

    • Year Range

      75.86 – 157.55

    • Market Cap

      5.0380 Bil

    • Volume / Avg

      5.0 k / 4.2 k

    • Price / Sales

      3.75

    • Price / Book

      2.15

    • Price / Earnings

      —

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Undervalued (16% Discount)
Fair ValueQ138.65UncertaintyHigh
Close Price115.95Jul 04, 2025
Market Closed
₹ 115.95
Price Up by 0.95 | 0.83 %
Trading Information Business Description
Previous Close
115.95
Day Range
115.45 – 118.95
Year Range
75.86 – 157.55
Bid / Ask
—
Market Cap
5.0 Bil
Volume / Average
5.0 k / 4.2 k
Beta (1-Year)
–
Shares Outstanding
43.45 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
Contact
Mulund Goregaon Link Road 104, Udyog Kshetra, Mulund, MH 400080
T +91 2249712001
www.valiantlabs.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
77
As of Mar 31, 2024

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
1.33 1.33 1.82 3.34 2.92 1.82
Revenue Growth %
-26.74% -26.74% -45.48% 14.54% 59.85% —
Gross Profit
0.17 0.17 0.14 0.49 0.52 0.58
Gross Profit Margin %
12.58% 12.58% 7.58% 14.73% 17.95% 32.02%
Operating Income
-0.07 -0.07 -0.10 0.34 0.40 0.47
Operating Margin %
-5.08% -5.08% -5.70% 10.13% 13.72% 25.99%
EBIT
-0.01 -0.01 -0.01 0.38 0.41 0.48
EBIT Margin %
-1.00% -1.00% -0.38% 11.47% 14.14% 26.56%
EBITDA
0.01 0.01 0.01 0.40 0.44 0.51
EBITDA Margin %
0.57% 0.57% 0.70% 11.94% 15.00% 27.99%
Net Income
-0.02 -0.02 — 0.29 0.27 0.31
Net Profit Margin %
-1.65% -1.65% 0.18% 8.68% 9.43% 16.78%
Basic EPS
-0.51 -0.51 0.13 6.67 6.33 7.04
Diluted EPS
-0.51 -0.51 0.13 6.67 6.33 7.04
Normalized EPS
— — — — — —
Total Dividends per Share
— — — — — —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
4.01 4.01 3.43 2.13 1.82 1.06
Total Liabilities
1.67 1.67 1.06 1.12 1.10 0.18
Total Debt
1.22 1.22 0.77 0.60 0.61 0.01
Total Equity
2.34 2.34 2.37 1.00 0.71 0.89
Cash And Cash Equivalents
0.05 0.05 0.12 0.01 — 0.04
Working Capital
1.33 1.33 1.96 1.00 1.07 0.70
Shares Outstanding (Mil)
— — — 43.45 — —
Book Value Per Share
53.93 53.93 54.51 — — —
Total Debt To Equity
0.52 0.52 0.32 0.60 0.86 0.01
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
09/2020
Cash From Operating Activities
0.01 0.02 0.56 0.02 0.09 —
Cash From Investing Activities
-0.53 -1.44 -0.55 -0.12 -0.17 —
Cash From Financing Activities
0.45 1.52 -0.01 0.06 0.11 —
Capital Expenditures
1.14 0.46 0.38 0.07 0.02 —
Free Cash Flow
-1.09 -0.44 -0.07 0.23 0.32 —
Change in Cash
-0.07 0.10 — -0.04 0.04 —

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

There is no Ownership data available.

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top